Searchable abstracts of presentations at key conferences in endocrinology

ea0009p161 | Thyroid | BES2005

The titration regimen is as effective and better tolerated than the block-replace regimen in the medical therapy of Graves' hyperthyroidism

Abraham P , Avenell A , Park C , Watson W , Bevan J

IntroductionAntithyroid drugs are widely used in the therapy of hyperthyroidism. This review (update of Cochrane review: Antithyroid drug regimen for treating Graves' hyperthyroidism. In: The Cochrane Library, Issue 4, 2003; with 4 additional trials) assesses the effects of dose, regimen and duration of antithyroid drug therapy for Graves' hyperthyroidism.MethodsThe Cochrane Controlled Trials Register, MEDLIN...

ea0009p176 | Thyroid | BES2005

Iodine deficiency goitre in the United Kingdom - the result of a vegan diet

Park C , Watson W , Bevan J , Abraham P

While iodine deficiency goitre is common worldwide, it is rarely described in the U.K. Vegan diet is the only real way for this deficiency to occur in the U.K. A MEDLINE search from 1966 revealed 1 reported case (Shaikh et al. Transient neonatal hypothyroidism due to a maternal vegan diet; Journal of Pediatric Endocrinology & Metabolism Jan 2003). We have identified 3 cases, which we will describe here.Case 1A 21-year-ol...

ea0005p44 | Clinical Case Reports | BES2003

Cyclical Cushing's syndrome associated with a pituitary gonadotrophinoma

Acharya S , Jones T , Suliman M , Park C , Watson W , Abraham P , Bevan J

Background: True cyclical Cushing's syndrome is rare and usually due to an ACTH-secreting corticotrophinoma. We describe a man with cyclical Cushing's syndrome of 15 years duration who had unexpected pituitary immunohistopathology.Clinical details: A 22-year-old man presented in 1986 with clinical features of Cushing's syndrome & urinary free cortisols up to 1800 nmol/24h, but normal low-dose DXM suppression, & normal pituitary and adrenals on CT. He was then lost ...

ea0003p36 | Clinical Case Reports | BES2002

Efficacy and safety of high dose testosterone therapy in partial androgen insensitivity

Bandyopadhyay S , Watson W , Park C , Abraham P , Philip S , Acharya S , Bevan J

Efficacy and Safety of High Dose Testosterone Therapy in Partial Androgen InsensitivityS. Bandyopadhyay, W.A.Watson, C. M.Park, P. Abraham, S. Philip, S. Acharya , J.S. Bevan. Department of Endocrinology, Aberdeen Royal Infirmary, Aberdeen, AB25 2ZN.INTRODUCTION: There have been few reports of the efficacy and safety of high dose androgen therapy in men with partial androgen insensitivity (PAI). We report on the responses of a p...

ea0003p40 | Clinical Case Reports | BES2002

Differentiated thyroid carcinoma with large bony metastases - what is the best approach?

Watson W , Park C , Abraham P , Bandyopadhyay S , Philip S , Acharya S , Samuel L , Bevan J

The high survival rate for patients with differentiated thyroid carcinoma (DTC) declines markedly in those with bony metastases. We compare the management of two patients with large dominant pelvic metastases.Case 1 63 year old man with R hip pain. Investigation revealed a 10cm lesion in the R hemi pelvis and subsequent imaging and biopsy revealed a 9th rib lesion and metastatic follicular DTC. He underwent 131 I ablation of the normal thyroi...

ea0003p48 | Clinical Case Reports | BES2002

Multidisciplinary management of Cushing's syndrome due to a malignant thymic carcinoid tumour

Park C , Watson W , Abraham P , Acharya S , Bandyopadhyay S , Philip S , Samuel L , Nicolson M , Bevan J

Thymic carcinoma is a rare but aggressive cause of ectopic ACTH secretion, with fewer than 100 reported cases.Hypokalaemic alkalosis was found in a 38 year old woman who presented with a 2-week history of leg swelling, fatigue and dyspnoea. She was not obviously Cushingoid.ACTH-dependent Cushing's Syndrome was confirmed biochemically: urinary free cortisol (UFC) >8500nmol/day and serum cortisol 4060nmol/l, (no suppression on 8...

ea0003p148 | Endocrine Tumours and Neoplasia | BES2002

Primary medical management of macroprolactinomas with cabergoline(CAB)

Philip S , Booth A , Abraham P , Kumaravel M , Watson W , Park C , Bandyopadhyay S , Acharya S , Bevan J

Objective: To establish the efficacy of CAB as primary and exclusive therapy in the management of macroprolactinomasMethod: Retrospective case note review of all patients with macroprolactinomas treated with CAB since the drug received a UK licence in 1994. Patients: Sixteen patients (8males, 8 females) with mean age at presentation of 42.3yrs (range 22-72 years) were treated with initial CAB doses ranging from 0.5-1mg/week (median 1mg/week). Results: T...

ea0003p150 | Endocrine Tumours and Neoplasia | BES2002

Patterns and mechanisms of hypercortisolism in association with phaeochromocytoma

Abraham P , Watson W , Park C , Philip S , Bandyopadhyay S , Acharya S , Talbot J , White A , Bevan J

Phaeochromocytoma in association with hypercortisolism is thought to be rare. However we have observed 4 cases in 3 years and question the rarity of this link. In each case there was a dominant adrenal mass (3.6-7.7cm) with contralateral adrenal hyperplasia. Three of the 4 tumours showed increased 123-I-mIBG uptake. Urinary catecholamines ranged from 872-22752nmol/24h (N < 600). Hypercortisolism was present in all 4 patients; sustained in 2 and cyclical in 2. Case 1 (JCEM ...